{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:23:29Z","timestamp":1770067409454,"version":"3.49.0"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,5,30]]},"DOI":"10.18632\/aging.205867","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T14:31:43Z","timestamp":1716820303000},"page":"9228-9250","source":"Crossref","is-referenced-by-count":4,"title":["Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis"],"prefix":"10.18632","volume":"16","author":[{"given":"Lei","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyan","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Mugaany","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"},{"name":"Health Science Center, Ningbo University, Ningbo 315211, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zetong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"},{"name":"Health Science Center, Ningbo University, Ningbo 315211, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Centre Lihuili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315040, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines.","volume":"6","author":"Jones","year":"2018","journal-title":"Gut"},{"key":"2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and Management of Primary Biliary Cholangitis.","volume":"11","author":"Jacobson","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis.","volume":"39","author":"Hudson","year":"2018","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review.","volume":"6","author":"Vesterhus","year":"2017","journal-title":"J Hepatol"},{"key":"5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/hep.31067","article-title":"The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis.","volume":"7","author":"Gores","year":"2020","journal-title":"Hepatology"},{"key":"6","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: A review.","volume":"2","author":"Ricciuto","year":"2020","journal-title":"World J Gastroenterol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis.","volume":"39","author":"Hirschfield","year":"2020","journal-title":"Lancet"},{"key":"8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/hep.31560","article-title":"Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.","volume":"7","author":"Horslen","year":"2021","journal-title":"Hepatology"},{"key":"9","doi-asserted-by":"publisher","first-page":"e31395","DOI":"10.1097\/MD.0000000000031395","article-title":"Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients.","volume":"10","author":"Feng","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1872-034X.2009.00527.x","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials.","volume":"3","author":"Xie","year":"2009","journal-title":"Hepatol Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.jhepr.2021.100248","article-title":"Real-world experience with obeticholic acid in patients with primary biliary cholangitis.","volume":"3","author":"De Gasperi","year":"2021","journal-title":"JHEP Rep"},{"key":"12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","article-title":"Nature's randomised trials.","volume":"36","author":"Humphries","year":"2005","journal-title":"Lancet"},{"key":"13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","article-title":"Genetics meets proteomics: perspectives for large population-based studies.","volume":"2","author":"Schwenk","year":"2021","journal-title":"Nat Rev Genet"},{"key":"14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease.","volume":"36","author":"Sigurdsson","year":"2018","journal-title":"Science"},{"key":"15","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1038\/s41467-019-11177-x","article-title":"Genome and epigenome wide studies of neurological protein biomarkers in the Lothian Birth Cohort 1936.","volume":"1","author":"Visscher","year":"2019","journal-title":"Nat Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.","volume":"2","author":"Boutin","year":"2020","journal-title":"Nat Metab"},{"key":"17","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1038\/s41467-020-20079-2","article-title":"Whole-genome sequencing analysis of the cardiometabolic proteome.","volume":"1","author":"Zeggini","year":"2020","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrg2579","article-title":"Detecting gene-gene interactions that underlie human diseases.","volume":"1","author":"Cordell","year":"2009","journal-title":"Nat Rev Genet"},{"key":"19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","article-title":"Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.","volume":"2","author":"Barrio-Hernandez","year":"2021","journal-title":"Nat Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","article-title":"Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome.","volume":"1","author":"Wood","year":"2021","journal-title":"Nat Commun"},{"key":"21","doi-asserted-by":"publisher","first-page":"104199","DOI":"10.1016\/j.ebiom.2022.104199","article-title":"Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study.","volume":"8","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"key":"22","doi-asserted-by":"publisher","first-page":"1052616","DOI":"10.3389\/fimmu.2023.1052616","article-title":"A large-scale plasma proteome Mendelian randomization study identifies novel causal plasma proteins related to primary biliary cholangitis.","volume":"1","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1111\/liv.14128","article-title":"Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.","volume":"3","author":"Muratori","year":"2019","journal-title":"Liver Int"},{"key":"24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis.","volume":"38","author":"Lindor","year":"2015","journal-title":"Lancet"},{"key":"25","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development.","volume":"9","author":"Casas","year":"2017","journal-title":"Sci Transl Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease.","volume":"5","author":"Halldorsson","year":"2021","journal-title":"Nat Genet"},{"key":"27","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"5","author":"Staley","year":"2020","journal-title":"Nat Genet"},{"key":"28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"61","author":"Mattsson","year":"2023","journal-title":"Nature"},{"key":"29","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Shihab","year":"2018","journal-title":"Elife"},{"key":"30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","article-title":"Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits.","volume":"9","author":"Visscher","year":"2018","journal-title":"Nat Commun"},{"key":"31","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.","volume":"1","author":"Plagnol","year":"2014","journal-title":"PLoS Genet"},{"key":"32","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018.","volume":"4","author":"Liu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1038\/s41598-019-43699-1","article-title":"Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases.","volume":"9","author":"Kulecka","year":"2019","journal-title":"Sci Rep"},{"key":"34","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate Use and Interpretation.","volume":"12","author":"Schwarte","year":"2018","journal-title":"Anesth Analg"},{"key":"35","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.3748\/wjg.v21.i25.7683","article-title":"Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.","volume":"2","author":"Reshetnyak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cld.2012.12.003","article-title":"Primary biliary cirrhosis: therapeutic advances.","volume":"1","author":"Levy","year":"2013","journal-title":"Clin Liver Dis"},{"key":"37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.","volume":"14","author":"Lindor","year":"2013","journal-title":"Gastroenterology"},{"key":"38","doi-asserted-by":"publisher","first-page":"105169","DOI":"10.1016\/j.phrs.2020.105169","article-title":"Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27.","volume":"16","author":"Liu","year":"2021","journal-title":"Pharmacol Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/labinvest.2011.138","article-title":"HSP27\/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II.","volume":"9","author":"Ortiz","year":"2012","journal-title":"Lab Invest"},{"key":"40","doi-asserted-by":"publisher","first-page":"e77383","DOI":"10.1371\/journal.pone.0077383","article-title":"Heat shock protein B1-deficient mice display impaired wound healing.","volume":"8","author":"Dean","year":"2013","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/acn3.51364","article-title":"Charcot-Marie-Tooth disease type 2F associated with biallelic HSPB1 mutations.","volume":"8","author":"Corti","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.expneurol.2017.08.002","article-title":"HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons.","volume":"29","author":"Kolb","year":"2017","journal-title":"Exp Neurol"},{"key":"43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1515\/CCLM.2010.043","article-title":"Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma.","volume":"4","author":"Lin","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"8635329","DOI":"10.1155\/2018\/8635329","article-title":"Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification.","volume":"201","author":"Chen","year":"2018","journal-title":"Dis Markers"},{"key":"45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s1097-2765(00)80331-7","article-title":"Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation.","volume":"4","author":"Hamada","year":"1999","journal-title":"Mol Cell"},{"key":"46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-022-04953-1","article-title":"Spatial profiling of early primate gastrulation in utero.","volume":"60","author":"Reik","year":"2022","journal-title":"Nature"},{"key":"47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2020.07.012","article-title":"LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-\u03b21\/Smad3 pathway.","volume":"12","author":"Li","year":"2020","journal-title":"Mol Immunol"},{"key":"48","doi-asserted-by":"publisher","first-page":"741151","DOI":"10.3389\/fphar.2021.741151","article-title":"Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291\/LEFTY2 Axis.","volume":"1","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"49","doi-asserted-by":"publisher","first-page":"e0230044","DOI":"10.1371\/journal.pone.0230044","article-title":"LEFTY2\/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells.","volume":"1","author":"Salker","year":"2020","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000321997","article-title":"Copy number variation of FCGR3B is associated with susceptibility to idiopathic pulmonary fibrosis.","volume":"8","author":"Hart","year":"2011","journal-title":"Respiration"},{"key":"51","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1084\/jem.20072413","article-title":"Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.","volume":"20","author":"Watts","year":"2008","journal-title":"J Exp Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1093\/rheumatology\/keaa134","article-title":"FCGR3B polymorphism predicts relapse risk in eosinophilic granulomatosis with polyangiitis.","volume":"5","author":"Percesepe","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"53","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jhep.2017.01.032","article-title":"Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.","volume":"6","author":"Mondelli","year":"2017","journal-title":"J Hepatol"},{"key":"54","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10238-015-0381-2","article-title":"Elevated circulating CD14(low)CD16(+) monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization.","volume":"1","author":"Zhuang","year":"2016","journal-title":"Clin Exp Med"},{"key":"55","doi-asserted-by":"publisher","first-page":"105385","DOI":"10.1016\/j.antiviral.2022.105385","article-title":"Increased ILT2 expression contributes to dysfunction of CD56(dim)CD16NK cells in chronic hepatitis B virus infection.","volume":"20","author":"Yin","year":"2022","journal-title":"Antiviral Res"},{"key":"56","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41416-018-0087-9","article-title":"Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).","volume":"11","author":"Guancial","year":"2018","journal-title":"Br J Cancer"},{"key":"57","doi-asserted-by":"publisher","first-page":"5021983","DOI":"10.1155\/2020\/5021983","article-title":"\u03b2-Phenethyl Isothiocyanate Induces Cell Death in Human Osteosarcoma through Altering Iron Metabolism, Disturbing the Redox Balance, and Activating the MAPK Signaling Pathway.","volume":"202","author":"Shang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"58","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells.","volume":"2","author":"Efferth","year":"2015","journal-title":"Phytomedicine"},{"key":"59","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41419-021-04367-3","article-title":"Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer.","volume":"1","author":"Ye","year":"2021","journal-title":"Cell Death Dis"},{"key":"60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.clindermatol.2007.10.028","article-title":"Alefacept in the treatment of psoriasis.","volume":"2","author":"Korman","year":"2008","journal-title":"Clin Dermatol"},{"key":"61","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2165\/00003495-199651050-00010","article-title":"Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.","volume":"5","author":"Goa","year":"1996","journal-title":"Drugs"},{"key":"62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/imt-2017-0155","article-title":"Etanercept for the treatment of rheumatoid arthritis.","volume":"1","author":"Moots","year":"2018","journal-title":"Immunotherapy"},{"key":"63","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/rheumatology\/key361","article-title":"Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.","volume":"5","author":"Spindler","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"64","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.cgh.2015.07.020","article-title":"Natalizumab for Crohn's Disease: Down but Not Out.","volume":"1","author":"Osterman","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:48:27Z","timestamp":1717602507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,30]]}},"alternative-id":["205867","38809509"],"URL":"https:\/\/doi.org\/10.18632\/aging.205867","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]}}}